Cytophage Technologies (TSXV:CYTO) Issuance of Stock : C$1.98 Mil (TTM As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Issuance of Stock?

Cytophage Technologies's Issuance of Stock for the three months ended in Mar. 2024 was C$2.50 Mil.

Cytophage Technologies's Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 was C$1.98 Mil.

Cytophage Technologies Issuance of Stock Historical Data

The historical data trend for Cytophage Technologies's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Issuance of Stock Chart

Cytophage Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Issuance of Stock

6.59

5.00

Cytophage Technologies Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Issuance of Stock	Get a 7-Day Free Trial			5.00	0.14	-	-0.52	2.50

Cytophage Technologies Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.98 Mil.

Cytophage Technologies Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies (TSXV:CYTO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Issuance of Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.